Search

Leafly reviewed and selected the best products around the nation for the July 4th weekend, perfect for fireworks, grilling, and chilling. < Back Fire products for fireworks, grilling & chilling this July 4th weekend Jun 27, 2025 Leafly Staff Leafly Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Find the best products for July 4th weekend. Leafly reviewed products for the holiday weekend & chose the best picks around the nation. The post Fire products for fireworks, grilling & chilling this July 4th weekend appeared first on Leafly. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The chamber’s lawmakers voted, 102-101, along party lines to pass the legislation, which aims to establish a state-run dispensary model < Back Pennsylvania Democrats ‘Ram’ Partisan Cannabis Legalization Bill Through House May 7, 2025 Cannabis Business Times Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The chamber’s lawmakers voted, 102-101, along party lines to pass the legislation, which aims to establish a state-run dispensary model < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Cannabis retailers in Arizona are recalling several batches of edibles and concentrates from PRESSD Brands and Baked Bros due to potential contamination with the pesticide Spinosad, which was discovered after investigators found a testing failure had been misreported as passing. This incident is separate from an earlier October recall concerning cannabis flower contaminated with Aspergillus and lead. < Back Arizona Officials Announce Cannabis Recall Over Pesticide Concerns Dec 23, 2025 Graham Abbott Ganjapreneur Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Cannabis retailers in Arizona are recalling some batches of edibles and concentrate products over possible contamination with the pesticide Spinosad, the Tucson Sentinel reports. The recalls target three batches of concentrates by PRESSD Brands and seven batches of edibles from Baked Bros, all created from distillates that were found to be potentially contaminated: - PRESSD Brands – Batch *2424.BMOC.LRFG* – Concentrate - PRESSD Brands – Batch *2424.G6.LRFG *– Concentrate - PRESSD Brands – Batch *2424.B.BANNER.LRFG* – Concentrate - Baked Bros – Batch *LHR100WS-16 *– Edibles (B.BANNER strain) - Baked Bros – Batch *LHR100AP-13 *– Edibles (G6 strain) - Baked Bros – Batch *LHR100AP-14 *– Edibles (G6 strain) - Baked Bros – Batch *LHR100BO-5 *– Edibles (G6 strain) - Baked Bros – Batch *LHR100WS-13* – Edibles (B.BANNER strain) - Baked Bros – Batch *LHR100VB-6* – Edibles (GMOC strain) - Baked Bros – Batch *LHR100VB-8 *– Edibles (GMOC strain) Spinosab is a natural insecticide that is considered generally safe and is approved for use by the U.S. Environmental Protection Agency (EPA) against agricultural pests like mites, thrips, and beetles. It can also be prescribed as a topical treatment for human head lice and scabies. The recall was issued after Arizona Department of Health Services (AZDHS) State Laboratory investigators found during a routine inspection at Kaycha Labs that a testing failure for the Spinosad had been misreported as a passing test, the report said. Officials said that once informed, the product manufacturers took action immediately to work with distribution and retail partners to initiate the recall. Meanwhile, health officials ordered another recall in October for two cannabis flower batches over concerns about potential Aspergillus and lead contamination. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Nebraska State Sen. John Cavanaugh filed a formal complaint against the state Medical Cannabis Commission and Gov. Jim Pillen regarding emergency regulations for medical cannabis. Cavanaugh argues that these regulations contradict what voters approved, restrict product selection, limit patient access to only 5 grams every 90 days instead of 5 ounces, and allow only in-state physicians to recommend medical cannabis. He also criticizes the commission for missing the October 1 deadline to issue cannabis licenses and believes these restrictions will make it difficult for patients to obtain medical cannabis in Nebraska. Cavanaugh is requesting a hearing on his complaint from the General Affairs Committee. < Back Nebraska Sen. Submits Complaint Against Medical Cannabis Commission’s Emergency Regulations Oct 7, 2025 TG Branfalt Ganjapreneur Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Nebraska state Sen. John Cavanaugh (D) last week submitted a formal complaint to the state Medical Cannabis Commission over the emergency regulations adopted by the commission and signed into law by Gov. Jim Pillen (R) last month. The complaint contends that the regulations run afoul of what voters approved and that the commission and governor “have chosen to override the clearly expressed will” of the public. “The Nebraska Medical Cannabis Commission has exceeded its statutory authority in adopting emergency regulations which conflict with both the voters’ intent and the plain language of the Nebraska Medical Cannabis Regulation Act and the Nebraska Medical Cannabis Patient Protection Act, while failing to meet statutory deadlines…” — Cavanaugh in the complaint In the complaint, Cavanaugh argues that the voter-approved proposal legalized “all forms of cannabis” for medical use and that the regulations offer patients only a narrow selection of products, namely oral tablets, capsules, tinctures, topicals, suppositories, patches, and liquids or oils for use with an inhaler or nebulizer. “The regulatory authority given to the commission over registered cannabis establishments was never intended to restrict delivery of forms clearly allowed by statute,” Cavanaugh wrote. “The Commission is not free to adopt its own definition of cannabis that is more restrictive than the definition contained in statute.” Cavanaugh called the regulatory ban on products like flower and concentrates “a transparent attempt to restrict access to medical cannabis and make it as difficult as possible for patients and caregivers to obtain it.” The complaint also argues that the law approved by voters would allow out-of-state physicians to recommend medical cannabis to Nebraska patients, but that the regulations allow recommendations from only pre-approved physicians within the state that have received training, which is outside the scope of the commission. Cavanaugh indicated he has contacted the state Board of Medicine in May about the training, but the board “had not had any communications regarding the issue.” Further, Cavanaugh says the rule limiting patients to 5 grams of medical cannabis within 90 days is “contained nowhere in the statute” approved by voters, which allowed up to 5 ounces for patients. “[Five] grams is 0.17637 ounces. 5 ounces is 141.748 grams. Under this limitation, a patient would not even be able to obtain an ounce of cannabis over the course of an entire calendar year,” Cavanaugh wrote in the complaint. “It would take seven years for a patient to obtain the maximum allowable amount of cannabis by statute under these restrictions.” Cavanaugh also took aim at the commission missing the October 1 statutory deadline to begin issuing cannabis licenses, calling the failure “a clear breach of the Commission’s duty.” “Lack of adequate planning does not constitute an emergency,” Cavanaugh wrote in the complaint. “The failure to follow these clear deadlines in statute create a legal risk that the commission’s actions will be nullified by the courts.” Cavanaugh contends that lawmakers were the only body that – with a two-thirds vote – could amend the law approved by voters and the commission’s “regulations only serve to make it more difficult to obtain medical cannabis in an environment where the state has some control and oversight” and ultimately the restrictions would drive “those who do need care out of Nebraska despite the fact that this state voted overwhelmingly in favor of medical cannabis.” Cavanaugh is asking the General Affairs Committee to hold a hearing on his complaint. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Attorney General Pam Bondi missed a deadline to issue guidelines for easing research barriers on Schedule I substances such as marijuana and psychedelics, while Congress is requiring a report from Customs and Border Protection on seizures from state-legal marijuana businesses. In state news, the Florida Senate approved a bill to ban public marijuana smoking as the state's AG pursued criminal investigations against the recreational legalization campaign. Business projections include Curaleaf forecasting at least $330 million in quarterly net revenue. < Back AG misses cannabis & psychedelics research rule deadline (Newsletter: January 21, 2026) Jan 21, 2026 Tom Angell Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *Congress wants CBP report on state-legal marijuana seizures; Book on Trump’s rescheduling move; FL cannabis public smoking ban; SC hemp op-ed* Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: *Your support makes Marijuana Moment possible…* *Your good deed for the day:* donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. - *Howard Wooldridge of Citizens Opposing Prohibition:* “Absolutely feel free to mention my and COP support for your vital, timely information. You know I do not butter anybody’s toast. Despite some differences we’ve had, your newsletter is vital to what I do on Capitol Hill. These members of Congress come from somewhere and you help fill in some gaps of what I don’t hear in the local media.” Support our work at https://www.patreon.com/marijuanamoment */ TOP THINGS TO KNOW* Attorney General Pam Bondi missed a congressionally mandated deadline to issue guidelines for easing barriers to research on Schedule I substances such as marijuana and psychedelics. House and Senate Appropriations Committee leaders released a funding bill and attached reports that would require Customs and Border Protection to provide a briefing on seizures of marijuana products from state-legal businesses, direct a health agency to publish information about cannabinoid hyperemesis syndrome and block transportation officials from encouraging illegal drug or alcohol use in impaired driving PSAs. Sen. Cory Booker (D-NJ) told Marijuana Moment that while there are “things that look promising” about the Trump administration’s cannabis rescheduling move, he is “very concerned about where the DOJ will land.” - Sen. Bernie Moreno (R-OH), meanwhile said that marijuana banking legislation remains “stacked ranked very low” as a priority “because we just have a lot of irons in the fire right now.” The Florida Senate Regulated Industries Committee approved a bill to ban smoking or vaping marijuana in public places, a development that comes as an industry-funded campaign is seeking to place a recreational cannabis legalization initiative on the November ballot. David Spang of Coastal Green Wellness authored an op-ed calling on South Carolina lawmakers to pass an amendment to create “a framework for responsible regulations for hemp-derived consumable products.” */ FEDERAL* The National Institute on Drug Abuse said in its newsletter that federal marijuana rescheduling will “facilitate cannabis research.” The Senate Health, Education, Labor & Pensions Committee removed mention of marijuana and other substances from a bill requiring the Department of Health and Human Services to study how frequently hospital emergency departments test for fentanyl. Rep. James Comer (R-KY) spoke on the House floor about how hemp is “an alternative crop to tobacco for Kentucky farmers.” */ STATES* Florida’s attorney general announced 46 new criminal investigations related to petitioning for a marijuana legalization initiative as well as the issuance of four criminal subpoenas seeking records from the campaign and its contractors and subcontractors. Separately, the campaign is urging the state Supreme Court to allow its initiative to appear on the November ballot. A Pennsylvania representative said he is working to build support for a bill to allow terminally ill patients to use medical cannabis in healthcare facilities. Tennessee lawmakers discussed pending marijuana legislation. The officially listed proponent of a Maine initiative to roll back marijuana legalization said he did not write it and was unaware it would end legal recreational cannabis sales. Massachusetts’s top marijuana regulator discussed efforts to reduce red tape faced by cannabis businesses. Utah regulators sent updates about the medical cannabis program. Minnesota regulators sent a newsletter with various cannabis updates. New Jersey regulators published a podcast episode about an official who provides support to cannabis businesses. The Alaska Marijuana Control Board Laboratory Testing Working Group will meet on Thursday. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* */ LOCAL* San Francisco, California regulators posted information about cannabis grants. */ INTERNATIONAL* UK Prime Minister Keir Starmer responded to a lawmaker’s question about pediatric medical cannabis access. */ SCIENCE & HEALTH* A study found that “legalization of medical marijuana is associated with lower loan spreads, particularly for firms that are more dependent on labor,” suggesting that “improved labor conditions serve as a key channel through which the policy affects financing costs.” A review concluded that “current evidence supports the short-term efficacy and safety of psychedelic-assisted therapy for selected psychiatric disorders, particularly depression and PTSD.” */ ADVOCACY, OPINION & ANALYSIS* A poll of U.S. adults found that 28 percent have positive attitudes toward psychedelic therapy, 28 percent have negative attitudes and 44 percent have neutral or mixed opinions. */ BUSINESS* Curaleaf Holdings, Inc. is projecting unaudited quarterly net revenue of at least $330 million. Glass House Brands Inc. announced it is accelerating its 2026 expansion plans. Kazmira Therapeutics is launching what it calls “a first-of-its-kind, prescription-only cannabinoid (CBD) pharmacy.” */ CULTURE* Former basketball player Lamar Odom smelled of marijuana before he was arrested for DUI, according to Nevada Highway Patrol officers. *Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.* Get our daily newsletter. Email address: Leave this field empty if you're human: The post AG misses cannabis & psychedelics research rule deadline (Newsletter: January 21, 2026) appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

In the lead-up to 4/20, Ohio cannabis sales jumped $3 million. From April 13-19, receipts at Ohio dispensaries surpassed $20 million. It was the first 4/20 since the launch of Ohio’s adult-use cannabis market in August 2024. Combined cannabis sales in the state totaled about $2.6 billion through April 19. < Back Ohio Saw $3M Cannabis Sales Jump Ahead of 4/20 Apr 24, 2025 TG Branfalt Ganjapreneur Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link In the lead-up to April 20 – or 4/20 – cannabis sales in Ohio jumped $3 million, MITechNews reports. From April 13-19, total cannabis receipts at Ohio dispensaries surpassed $20 million, according to Ohio Division of Cannabis Control (DCC) data. It was the first 4/20 since the launch of Ohio’s adult-use cannabis market in August 2024. Adrienne Robbins, the deputy executive director for the Ohio Cannabis Coalition (OHCANN), told MITechNews that the sales are “really impressive” and makes the organization “very hopeful for the future as well.” “Years ago we probably didn’t know if we were going to reach this day or not, as far as sales go for the industry this has been a high sale weekend for them.” — Robbins to MITechNews In the six weeks leading up to April 20, Ohio dispensaries averaged more than 260,000 transactions each week. According to DCC data, as of April 21, there are 140 dispensaries throughout the state that sell both medical and adult-use cannabis products. Since adult-use sales launched in the state, through April 19, combined cannabis sales in the state totaled about $2.6 billion. Including about $2.1 billion in adult-use sales and about $466 million in medical cannabis sales. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Green Blazer solves the problem of running out of pre-rolled cones by optimizing a delivery system for RAW pre-rolled cones and rolling papers. They offer efficient networks for both pre-roll producers/distributors and cannabis lovers, aiming to reduce stress and increase enjoyment for their customers. The company started by addressing the high cost of single cones at smoke shops, leveraging e-commerce and logistics to offer authentic RAW cones at a 90% lower price with one-day fulfillment. RAW cones are favored for their consistent quality, slow burn, and use of clean, unrefined plant fibers. Green Blazer's mastery of the supply chain enables speedy and reliable delivery for both B2C and B2B customers, with fulfillment centers in Nevada and Indiana for nationwide two-day delivery for businesses. They also offer the #1 best-selling DIY RAW Cone kit on Amazon with rapid delivery and subscription options. With over 100,000 five-star Amazon reviews and a 100% success rate, Green Blazer focuses on customer satisfaction, integrity, and continuous learning, ensuring a convenient, fast, and trustworthy experience for RAW cones. < Back Green Blazer: Optimizing RAW Cones Delivery to Manufacturers and Smokers Sep 11, 2025 Cannabis Now Cannabis Now Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link If you love to roll your own joints, you know the frustration of running out of cones. The hassle of searching for a smoke shop, paying a high price and sometimes even worrying about whether you’re buying the real deal can take the relaxation out of the experience. That’s where Green Blazer comes in. The company built its reputation by solving this very problem, optimizing a delivery system that takes the stress out of stocking up on your favorite RAW pre-rolled cones and rolling papers. Today, they operate two incredibly efficient networks: one tailored to pre-roll producers and distributors and one for cannabis lovers. The company’s mission is simple: to make sure you spend less time worrying about cones and more time enjoying your weed. From Simple Idea to Game-Changing Solution Green Blazer’s origin story began with an all-too-common frustration: paying a dollar for a single cone at a local smoke shop. The founders knew they could do better and set out to provide cannabis lovers with the best pre-rolled cones at the best price and with the best service. Drawing on their background in e-commerce and logistics, the founders streamlined the way people source RAW cones, whether they’re filling one cone at home or 10,000 on a production line. By creating a reliable online delivery system for authentic RAW cones, they were able to drop the price per cone by 90% and offer one-day fulfillment. They also quickly realized that the cones themselves were a key part of the solution. RAW cones are renowned for their consistent quality, with an ultra-thin paper and a signature watermark that helps them burn slowly and evenly. This preserves the flavor of the cannabis and makes for a smoother smoking experience, which is why they’re a favorite among consumers and a top search on platforms like Google, Amazon and TikTok. The cones are also made with clean, unrefined, chlorine-free plant fibers and natural acacia gum, aligning with the growing demand for sustainable products. *Your Supply Chain, Mastered* Green Blazer’s real edge is in its mastery of the supply chain, which they’ve used to build a robust B2C delivery system over seven years. This network is engineered for speed and reliability, ensuring you get authentic RAW cones right when you need them. For business customers, Green Blazer has established itself as the preeminent national supplier of authentic RAW cones. They serve licensed pre-roll manufacturers, distributors, co-packers and cultivators with dedicated B2B services. With fulfillment centers in Nevada and Indiana, they can ensure two-day delivery nationwide. Their system is built for the needs of large-scale operations, offering same-day invoicing and shipping with a RAW cone price match guarantee. This commitment to efficiency is a core part of their service. The cones are manufactured under an ISO 9001-certified quality system, which ensures consistent sizing and reduces machine jams, a huge benefit for automated pre-roll lines. For consumers, Green Blazer operates the #1 best-selling DIY RAW Cone kit on Amazon, and its system is so efficient that most orders arrive in as little as one day. Their DIY kits include everything you need to fill a cone, including a cone loader, packing stick and storage tube, making the process easy and mess-free. For people who prefer a steady supply, the company offers subscription savings through Amazon’s Subscribe & Save program. This optimized system takes the hassle out of rolling, so you can “roll less, relax more.” With over 100,000 five-star reviews on Amazon, Green Blazer has a proven track record of customer satisfaction and a 100% success rate over the last seven years. They also protect their brand by identifying and removing fraudulent or inauthentic sellers from the platform. Their deep engagement with Amazon’s retail ecosystem does more than enable fast, reliable access to RAW cones; it offers a window into real consumer habits. These insights help Green Blazer support pre-roll manufacturers, aligning production with real-world demand and preferences across cone types and formats. *A Brand of Service Built on Integrity* Behind all the logistics and technology is a simple core value: doing right by the customer, every single time. This belief is what sets Green Blazer apart and is reflected in their 100% satisfaction guarantee. If something isn’t right, you’ll get an instant refund or replacement—no questions asked. Green Blazer’s core values of integrity, urgency and learning through failure guide their decision-making. The goal isn’t just to fix problems, but to make sure every experience keeps you coming back with confidence. Green Blazer believes that cannabis is a positive force in people’s lives and they’re here to make that experience more accessible with tools and systems you can rely on. With Green Blazer, you’re buying more than a product; you’re buying into a guarantee of convenience, speed and integrity. You get the same great RAW cones you know and love, backed by a company that’s obsessed with getting them to you in the most reliable, hassle-free way possible The post Green Blazer: Optimizing RAW Cones Delivery to Manufacturers and Smokers appeared first on Cannabis Now. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

DEA Says Marijuana Rescheduling Process Is Still Stalled Six Months Into Trump Administration < Back DEA Says Marijuana Rescheduling Process Is Still Stalled... Jul 8, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Drug Enforcement Administration (DEA) has again notified an agency judge that the marijuana rescheduling process remains stalled under the Trump administration. It’s been six months since DEA Administrative Law Judge (ALJ) John Mulrooney temporarily paused hearings on a proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) that was initiated under the Biden administration. And in a joint report to the judge submitted on Monday, DEA attorneys and rescheduling proponents said they’re still at an impasse. “To date, Movants’ interlocutory appeal to the Acting Administrator regarding their Motion to Reconsider remains pending with the Acting Administrator. No briefing schedule has been set,” the notice says. This comes 90 days after both parties sent the judge an identical update, albeit when a different acting administrator was in charge. DEA and the witnesses involved in the interlocutory appeal must provide another update in 90 days. But for the time being, any action on the proposed rule to reschedule marijuana is evidently contingent on DEA Acting Administrator Robert Murphy. Murphy’s appointment as acting administrator wasn’t widely publicized, but he’s replaced Derek Maltz—who subscribes to the “gateway drug” theory for marijuana— in the role as the Senate considers confirming President Donald Trump’s pick to lead the agency, Terrance Cole. Whereas Maltz, the former acting administrator, made his opposition to cannabis reform known in numerous social media posts and TV interviews before taking on the leadership role, Murphy’s position on the issue is less clear—though it is notable that he did speak at an event hosted by prohibitionist organization Smart Approaches to Marijuana in 2018. A summary of the appearance from the group says he “addressed the conference on the reality that black markets are thriving off of marijuana originating in states that legalized the substance and took a moment to remind everyone that medical and recreational marijuana is still illegal under federal law.” In May, a Senate committee advanced the nomination of Cole to become DEA administrator amid the ongoing review of the marijuana rescheduling proposal that he has so far refused to commit to enacting. Cole—who has previously voiced concerns about the dangers of marijuana and linked its use to higher suicide risk among youth—said in response to senators’ written questions that he would “give the matter careful consideration after consulting with appropriate personnel within the Drug Enforcement Administration, familiarizing myself with the current status of the regulatory process, and reviewing all relevant information.” However, during an in-person hearing before the Senate Judiciary Committee in April, he said examining the rescheduling proposal will be “one of my first priorities” if he was confirmed for the role, saying it’s “time to move forward” on the stalled process—but again without clarifying what end result he would like to see. Mulrooney, the agency judge, initially agreed to delay the proceedings after several pro-rescheduling parties requested a leave to file an interlocutory appeal amid allegations that certain DEA officials conspired with anti-rescheduling witnesses who were selected for the hearing. The DEA judge initially agreed to delay the proceedings after several pro-rescheduling parties requested a leave to file an interlocutory appeal amid allegations that certain DEA officials conspired with anti-rescheduling witnesses who were selected for the hearing. Originally, hearings were set to commence on January 21, but those were cancelled when Mulrooney granted the appeal motion. He ordered DEA and the witnesses to provide a joint status update within 90 days, which would be this coming Sunday. The appeal came after the judge denied a motion that sought DEA’s removal from the rescheduling proceedings altogether, arguing that it is improperly designated as the chief “proponent” of the proposed rule given the allegations of ex parte communications with anti-rescheduling witnesses that “resulted in an irrevocable taint” to the process. Meanwhile, the Justice Department told a federal court in January that it should pause a lawsuit challenging DEA’s marijuana rescheduling process after Mulrooney canceled the hearings. Also in January, Mulrooney condemned DEA over its “unprecedented and astonishing” defiance of a key directive related to evidence it is seeking to use in the marijuana rescheduling proposal. At issue was DEA’s insistence on digitally submitting tens of thousands of public comments it received in response to the proposed rule to move cannabis to Schedule III. Mulrooney hasn’t been shy about calling out DEA over various procedural missteps throughout this rescheduling process. For example, in December he criticized the agency for making a critical “blunder” in its effort to issue subpoenas to force Food and Drug Administration (FDA) officials to testify in hearings—but he allowed the agency to fix the error and ultimately granted the request. Relatedly, a federal judge also dismissed a lawsuit seeking to compel DEA to turn over its communications with the anti-cannabis organization. Mulrooney had separately denied a cannabis research company’s request to allow it to add a young medical marijuana patient and advocate as a witness in the upcoming rescheduling hearing. Also, one of the nation’s leading marijuana industry associations asked the judge to clarify whether it will be afforded the opportunity to cross-examine DEA during the upcoming hearings on the cannabis rescheduling proposal. Further, a coalition of health professionals that advocates for cannabis reform recently asked that the DEA judge halt future marijuana rescheduling hearings until a federal court is able to address a series of allegations they’re raising about the agency’s witness selection process. The rescheduling proceedings have generated significant public interest. While moving marijuana to Schedule III wouldn’t federally legalize it, the reform would free up licensed cannabis businesses to take federal tax deductions and remove certain research barriers. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* Meanwhile, two GOP senators introduced a bill in February that would continue to block marijuana businesses from taking federal tax deductions under Internal Revenue Service (IRS) code 280E—even if it’s ultimately rescheduled. Beyond the hearing delays, another complicating factor is the change in leadership at DEA under the Trump administration. U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. was previously vocal about his support for legalizing cannabis, as well as psychedelics therapy. But during his Senate confirmation process in February, he said that he would defer to DEA on marijuana rescheduling in his new role. Separately, former Rep. Matt Gaetz (R-FL) was reportedly photographed reviewing a document that appears to be a draft contract to provide services—including “administration-related guidance”—to a firm affiliated with the major marijuana company Trulieve. The visible portion of the document describes a lucrative bonus if a certain “matter resolves,” with an “additional ‘Super Success Fee’” for other “exclusive policy remedies.” Last month, the former congressman reiterated his own support for rescheduling cannabis—suggesting in an interview with a Florida Republican lawmaker that the GOP could win more of the youth vote by embracing marijuana reform. Gaetz also said last month that Trump’s endorsement of a Schedule III reclassification was essentially an attempt to shore up support among young voters rather than a sincere reflection of his personal views about cannabis. A survey conducted by a GOP pollster affiliated with Trump that was released in April found that a majority of Republicans back a variety of cannabis reforms, including rescheduling. And, notably, they’re even more supportive of allowing states to legalize marijuana without federal interference compared to the average voter. Meanwhile, Trump picked former Florida Attorney General Pam Bondi (R) to run DOJ, and the Senate confirmed that choice. During her confirmation hearings, Bondi declined to say how she planned to navigate key marijuana policy issues. And as state attorney general, she opposed efforts to legalize medical cannabis. Amid the stalled marijuana rescheduling process that’s carried over from the last presidential administration, congressional researchers recently reiterated that lawmakers could enact the reform themselves with “greater speed and flexibility” if they so choose, while potentially avoiding judicial challenges. Meanwhile, a newly formed coalition of professional athletes and entertainers, led by retired boxer Mike Tyson, sent a letter to Trump on Friday—thanking him for past clemency actions while emphasizing the opportunity he has to best former President Joe Biden by rescheduling marijuana, expanding pardons and freeing up banking services for licensed cannabis businesses. *Read the joint update to the DEA judge on the marijuana rescheduling process below:* *Photo courtesy of Brian Shamblen.* The post DEA Says Marijuana Rescheduling Process Is Still Stalled Six Months Into Trump Administration appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Washington, DC's Premier I71 Compliant Art Gallery. At the Metropolitan Art & Sculpture Collaboration you can discover the beautiful works our artists currently have on show as well as all the wonderful gifts we have available. We work hard to surprise and innovate, designing and redesigning our space to carefully compliment our artists’ work and making sure our customers have highly enjoyable gifting experiences. MASC WEBSITE MENU REVIEWS 1528 U St. Washington, DC, 20009 United States (202) 290-9596 Washington, DC's Premier I71 Compliant Art Gallery! At the Metropolitan Art & Sculpture Collaboration you can discover the beautiful works our artists currently have on show as well as all the wonderful gifts we have available. We work hard to surprise and innovate, designing and redesigning our space to carefully compliment our artists’ work and making sure our customers have highly enjoyable gifting experiences. Hours: Mon-Sat 12-8pm, Sun 12-6pm MASC Reviews Recent Reviews Sodalicious - MASC Here's another batch of exotic designer flower from DC i-71 marijuana dispensary, MASC. This time it's the Sodalicious strain and the nam... Toker's Guide Sep 28, 2023 1 min read Basqui Gumbo - MASC The latest and greatest offering from DC i-71 marijuana dispensary, MASC, is the Basqui Gumbo Strain. These buds immediately caught my ey... Terp Interpreter Sep 7, 2023 1 min read Sriracha Fumi - MASC Get ready to heat things up with this Sriracha Fumi strain available now at DC i-71 marijuana dispensary, MASC. Just like a splash of Sri... Terp Interpreter Aug 17, 2023 1 min read Donut Runtz - MASC With a fun looking pack and a sweet aroma this batch of Donut Runtz from DC i-71 storefront dispensary, MASC, is ready to help you get yo... Toker's Guide Jul 21, 2023 2 min read Happy Dab Day! Here Are Five Dab-Worthy Concentrates in DC Right Now Why is July 10th known as Dab Day, you might ask? It's quite simple really. If you turn 710 around and upside down it spells "OIL" and th... Toker's Guide Jul 10, 2023 4 min read Italian Ice - MASC Take a look at this Italian Ice from DC Art Gallery and i-71 storefront dispensary, MASC. I remember being a kid and getting so excited w... Terp Interpreter Jun 30, 2023 2 min read Blue Gushers - MASC If you haven't checked out DC i-71 cannabis dispensary, MASC, now is a great time to stop on by. There've got this delectable batch of ex... Toker's Guide Jun 21, 2023 1 min read Lemon Poppers - MASC This batch of Lemon Poppers from DC i-71 storefront, MASC, is a deliciously cheesy, sour citrus smelling varietal that will pick you up... Elle Weeds May 11, 2023 1 min read Pine Zol - MASC With a nose similar to Lemon Cherry Gelato, but with more piney elements, this batch of Pine Zol from DC i-71 storefront dispensary, MASC... Toker's Guide Apr 29, 2023 1 min read Wonderland Watermelon Infused Vegan Gummies - MASC These Wonderland Watermelon Gummies are just what I needed this week! This is because my throat had been itchy and scratchy all thanks... Ben from Kannabus Feb 28, 2023 2 min read Cream - MASC This Cream from DC i-71 storefront MASC (Metropolitan Art & Sculpture Collaboration) has a remarkably creamy aroma and is a super smooth ... Elle Weeds Feb 4, 2023 1 min read Motordrip by Magnolia Pharms - MASC After the wonderful experience I had with the Magnolia Pharms DS11 recently I was stoked to see more of their jars at DC recreational... Toker's Guide Dec 17, 2022 2 min read DS11 by Magnolia Pharms - MASC The jar comes with an outer cellophane wrap as well as an internal seal, so you know this one is still fresh and ready to rock. Even... Toker's Guide Nov 29, 2022 2 min read Super Lemon Cherry Gelato by The Wizard of Za - MASC The first thing I noticed about this batch of Super Lemon Cherry from DC recreational (i-71) storefront MASC was how downright pretty it... Sophie Oct 7, 2022 2 min read Georgetown Pressure by Terp Lords & The Wizard of Za - MASC According to the Urban Dictionary "pressure" is "that bomb ass weed" or "weed that will make you suffocate". After taking a peek at this... Toker's Guide Sep 23, 2022 2 min read Terpadelic - MASC Back for another strain review and this time, I’m smoking on some chronic nugs cultivated by Terplords and available from DC recreational... Ben from Kannabus Aug 11, 2022 3 min read Rock Creek Fruit Punch - MASC If you're not familiar with the Metropolitan Art and Sculpture Collaboration, or MASC for short, they're a DC recreational (i-71)... Toker's Guide Jul 26, 2022 2 min read

Virginia senators advanced a bill to legalize and regulate recreational marijuana sales, which passed the Senate Rehabilitation & Social Services Committee and is now heading to the Senate Courts of Justice Committee. The legislation, which has the support of the new Governor Abigail Spanberger, aims to establish a commercial market by January 1, 2027, and includes details on taxation, purchase limits, THC caps, and the creation of the Virginia Cannabis Control Authority. < Back Virginia Senators Approve Bill To Legalize Marijuana Sales Under New Pro-Reform Governor Jan 23, 2026 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Virginia senators have advanced a bill to legalize and regulate recreational marijuana sales—one of several reform proposals under consideration as the 2026 session gets underway. The Senate Rehabilitation & Social Services Committee on Friday took up two marijuana sales legalization measures. After amending one of the proposals from Sen. Lashrecse Aird (D) with a substitute version, it passed the panel in a 8-7 vote. The bill largely aligns with recommendations released last month by the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market. Since legalizing cannabis possession and home cultivation in 2021, Virginia lawmakers have worked to establish a commercial marijuana market—only to have those efforts consistently stalled under former Gov. Glenn Youngkin (R), who twice vetoed measures to enact it that were sent to his desk by the legislature. “In 2021 Virginia became the first southern state to legalize adult use cannabis, and five years later, Virginia has yet to implement the marketplace we originally envisioned,” Aird said on Friday. “Each year that we go without a marketplace, the illicit market grows and health and safety concerns rise for our citizens.” “The legislation establishes a market, once and for all, that will protect consumers, protect health and safety while ensuring balance by creating a market that takes into account the harms created by the disproportionate enforcement of cannabis laws felt by Black and brown communities,” she said. Under the measure as revised by the committee, adult-use cannabis sales could begin on January 1, 2027. The Senate committee also considered a separate cannabis sales measure sponsored by Sen. Aaron Rouse (D), and incorporated it into Aird’s bill, which will be the main vehicle for the reform this session. The overall legislation, which next heads to the Senate Courts of Justice Committee, will help to “ensure our communities are safe,” Rouse told the committee on Friday. “In recent years we’ve seen an unchecked proliferation of illegal and unregulated marijuana stores,” he said. “This has put Virginias at risk as unlicensed drug dealers sells billions of dollars of untested and untaxed products, frequently to children. A well-regulated marijuana retail market is a necessity for public safety and would ensure that products are tested for safety, that they are accurately labeled, sold in a controlled environment and kept away from kids.” On the House side, members of the General Laws Subcommittee are also slated to hold a hearing on Friday afternoon on a marijuana sales legalization bill from Del. Paul Krizek (D), who chaired the joint commission that produced the regulatory recommendations. That legislation mirrors Aird’s own bill as filed prior to being amended. *Here are the key details of the Virginia marijuana sales legalization legislation:* - Retail sales could begin on January 1, 2027. - Adults would be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. - The Virginia Cannabis Control Authority would oversee licensing and regulation of the new industry. Its board of directors would have the authority to control possession, sale, transportation, distribution, delivery and testing of marijuana. - A tax of up to 11.625 percent would apply to the retail sale of any cannabis product. That would include a state retail and use tax of 1.125 percent on top of a new marijuana-specific tax of 8 percent. Local governments could levy an additional 3.5 percent. - Tax revenue would be split between the costs of administering and enforcing the state’s marijuana system, a new Cannabis Equity Reinvestment Fund, pre-kindergarten programs, substance use disorder prevention and treatment programs and public health programs such as awareness campaigns designed to prevent drug-impaired driving and discourage underage consumption. - Local governments could not opt out of allowing marijuana businesses to operate in their area. - Delivery services would be allowed. - Serving sizes would be capped at 10 milligrams THC, with no more than 100 mg THC per package. - Existing medical cannabis operators could enter the adult-use market if they pay a $10 million licensing conversion fee. - Cannabis businesses would have to establish labor peace agreements with workers. - A legislative commission would be directed to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations. It would also investigate the possibility of the Virginia Alcoholic Beverage Control Authority becoming involved in marijuana regulations and enforcement. Newly sworn-in Gov. Abigail Spanberger (D) supports legalizing adult-use marijuana sales. “Right now is that we live in this gray space where there’s some legality to marijuana, there’s some illegality,” she said ahead of taking office. “There’s a lot of questions—a lot of confusion—and that creates real problems for Virginians who might currently have the legal ability to buy it for medicinal needs, or for those who might try to fall under the personal use.” *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* Meanwhile, Virginia lawmakers have filed other marijuana-related legislation for the 2026 session, including proposals to provide resentencing relief for people convicted of past cannabis crimes and to let terminally ill patients use medical marijuana in hospitals and other healthcare facilities. Separately, the Virginia Department of Labor and Industry recently published a new outlining workplace protections for cannabis consumers. The post Virginia Senators Approve Bill To Legalize Marijuana Sales Under New Pro-Reform Governor appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Budget-friendly marketing for the cannabis industry requires resilient distribution channels that are not dependent on platform policies. The four key strategies are: using RSS feeds for redistributable content; building resilience through consistent messaging; leveraging retailer co-distribution for amplified reach; and prioritizing audience needs over ego when shaping content. The goal is to build durable reach through consistency and versatile, owned channels. < Back 4 Restriction-Proof Ways to Get Cannabis Content Seen Oct 27, 2025 Danny Reed MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Digital marketing is more accessible than ever — but in cannabis, it’s also more expensive, more restricted, and more fragile. Paid campaigns can still play a role, but enforcing a real audience moat requires channels that don’t disappear when a platform changes its policy. That’s why forward-looking marketers are leaning into resilient distribution — the kind you own, co-own, or can syndicate. *1. Use RSS to turn every post into a redistributable asset* RSS is one of the most overlooked distribution tools in cannabis — not because it’s outdated, but because it was *never dependent on platform approval.* It’s instantly portable, permission-based, and re-publishable by any partner or aggregator that wants to syndicate your content. “One of the cheapest ways — basically free — a brand can distribute content is by using an RSS feed,” said Growth Skills founder and Chief Executive Officer Lavall Chichester. “Most content management systems like WordPress automatically create one for you and update it every time you publish. “Other websites can pull the RSS feed and surface your content on their site,” he added. “Brands can even monetize that through licensing.” *Takeaway:* If it lives in your RSS feed, it can live beyond your website — which means you’re not waiting for an algorithm to grant you reach. ------------------------------ *2. Build resilience through consistency, not one-off pushes* Because cannabis brands can’t rely on frequency-boosting ad auctions the way mainstream consumer packaged goods brands can, consistency is the currency of visibility. Showing up repeatedly in the same voice and values is how audiences learn to recognize and trust a message, especially when distribution volume is limited by regulation. “The trick to a successful content-distribution strategy, regardless of budget, is consistency,” said Will Read, founder and chief executive officer of CannaPlanners. “Internal perception is key. What is your mission? What are your core values, and are those understood from the top down?” Owned media — newsletters, blogs, and direct community touchpoints — give cannabis companies the staying power that social platforms can revoke at any moment. *Takeaway:* Reach may fluctuate, but consistency compounds. ------------------------------ *3. Borrow audience reach through retailer co-distribution* Retailers already have distribution — not just of product, but also of attention. When co-branded content moves through retailer channels, the brand earns amplified trust and reach without paying for platform access. “Cannabis brands can boost visibility on a budget by collaborating directly with retailers,” said Brendan McKee, co-founder and chief operating officer at Silver Therapeutics. “Spotlighting retail partners in email newsletters and posts not only promotes them, but encourages them to return the favor.” This isn’t swag tables and passive signage; it’s co-authored storytelling. And because retailers already sit inside an audience relationship, the lift is instant. *Takeaway:* Every retailer partnership can be a distribution lane when it’s framed as shared storytelling, not just shelf space. ------------------------------ *4. Let the audience, not ego, determine what travels* In a restricted marketing environment, performance isn’t about shouting louder. It’s about aligning content with what the audience actually values enough to pass along. The brands winning organic reach are the ones adapting quickly instead of defending creative sacred cows. “One piece of advice I offer clients that does not cost anything is to watch your ego and be comfortable adapting your message if it doesn’t meet the needs of the audience,” said Jim Dissett, chief communications officer at The 9th Block. “Everyone thinks their baby is the most beautiful baby in the world, but sometimes your baby just ain’t that beautiful.” *Takeaway:* Reach is earned when the message is shaped by the receiver, not the sender. ------------------------------ At the end of the day, budget-friendly marketing isn’t about cutting corners. It’s about building durable reach through consistency, versatility, and channels that can’t be taken away. When you pair audience-aligned messaging with resilient distribution, you can earn visibility that lasts. Low cost doesn’t have to mean low impact. It just requires strategy over spray-and-pray. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The House Appropriations Committee approved a bill to block the Trump administration from rescheduling marijuana, while also continuing a separate rider protecting state medical cannabis programs from federal interference. < Back Congressional committee moves to block cannabis rescheduling (Newsletter: September 12, 2025) Sep 12, 2025 Tom Angell Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *Trump admin to warn about marijuana & youth; GOP senator: Don’t take THC out of hemp; NH legalization hearing; TX cannabis poll* Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: *Your support makes Marijuana Moment possible…* *BREAKING*: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment */ TOP THINGS TO KNOW* The House Appropriations Committee approved a bill to block the Trump administration from rescheduling marijuana, while also continuing a separate rider protecting state medical cannabis programs from federal interference. The Trump administration’s Make America Healthy Again Commission is recommending the U.S. surgeon general launch an educational campaign on the impact of THC on youth health as part of a new “Make Our Children Healthy Again Strategy.” Sen. Rand Paul (R-KY) said congressional proposals to criminalize hemp products with a quantifiable amount of THC would “eradicate the hemp industry.” - “I don’t think anybody will buy those products, because, frankly, the THC– even a little bit of it—is probably what helps to make people more calm, sleep better or [have] less anxiety.” The New Hampshire House Commerce and Consumer Affairs Committee plans to move forward with a marijuana legalization bill despite opposition from Gov. Kelly Ayotte (R) and the Senate—with the sponsor saying, “Let them be the ones that are pissing off voters who care about this.” A new poll of Texas voters found that 48 percent want marijuana laws to be made less strict, 16 percent think they should stay the same and 22 percent want cannabis criminalization to be even more strict. */ FEDERAL* Rep. Greg Steube (R-FL) authored an op-ed in support of federal marijuana rescheduling. Former Sen. Kyrsten Sinema (I-AZ) discussed her experience with ibogaine. The House bill to designate psychedelic therapy centers of excellence got one new cosponsor for a total of 12. */ STATES* Ohio Gov. Mike DeWine (R) said that today’s cannabis is “much, much more potent” than “your father’s marijuana.” Texas’s agriculture commissioner praised Gov. Greg Abbott’s (R) hemp executive order. A signature gatherer for a Florida marijuana legalization campaign has been charged with alleged petition fraud and perjury. A Maryland court upheld restrictions on intoxicating hemp products. New York regulators are being sued by a chain of unlicensed marijuana shops in an effort to shut down licensed stores that were deemed too close to schools amid confusion about zoning policy. New Jersey regulators are asking local leaders to complete a survey to help them “understand how municipalities are approaching cannabis operating within their towns, such as business caps and how cannabis revenue supports municipal budgets.” Michigan regulators filed a complaint against a marijuana business over alleged violations. Colorado regulators published average market rates for retail marijuana. Oregon regulators posted quarterly data about the psilocybin services program. The Illinois Medical Cannabis Advisory Board will meet on Monday. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* */ LOCAL* A Kansas City, Missouri City Council member is proposing legislation to allow marijuana social use lounges. The St. Cloud, Minnesota Planning Commission approved a request for a medical cannabis dispensary to add recreational marijuana sales. */ INTERNATIONAL* New Zealand lawmakers are set to debate a bill to protect people from drug charges if they are seeking help in the event of overdose. The Victoria, British Columbia, Canada City Council rejected a proposal to send a letter opposing the renewal of the province’s drug decriminalization policy. */ SCIENCE & HEALTH* A study found that “cannabidiol is associated with improved survival in pancreatic cancer and modulation of bile acids and gut microbiota.” A review concluded that “while available studies on psychedelics suggest potential benefit in cluster headache and migraine, access remains complex due to legal considerations, and additional studies are needed to confirm their effectiveness and to ensure safety before they can be recommended for use.” */ ADVOCACY, OPINION & ANALYSIS* The International Network of People Who Use Drugs, Harm Reduction International and International Drug Policy Consortium led a letter calling on the World Health Organization to continue supporting harm reduction approaches to drug policy. */ BUSINESS* Arkansas dispensaries have sold more than $193 million worth of medical cannabis products so far in 2025. *Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.* Get our daily newsletter. Email address: Leave this field empty if you're human: The post Congressional committee moves to block cannabis rescheduling (Newsletter: September 12, 2025) appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5